查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1375987

尿道感染檢測市場規模、佔有率和趨勢分析報告：按類型、最終用途、地區、細分市場趨勢，2023-2030 年

Urinary Tract Infection Testing Market Size, Share & Trends Analysis Report By Type (Urethritis, Cystitis, Pyelonephritis), By End Use (Reference Laboratories, General Practitioners, Urologists, Urgent Care), By Region, & Segment Forecasts, 2023-2030
出版日期: | 出版商: Grand View Research | 英文 113 Pages | 商品交期: 2-10個工作天內

價格

尿道感染檢測市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，到2030年，全球尿道感染檢測市場規模預計將達到8.1201億美元。

預計 2023 年至 2030 年該市場將以 4.4% 的年複合成長率成長。尿道感染(UTI) 檢測市場受到不斷上升的疾病負擔、不斷成長的老年人口、快速的技術進步以及自我檢測和快速照護端 (PoC) 設備產品等新穎和創新產品的推動。成長歸因於主要企業實施高額研發投入等因素。

尿道感染正成為全世界共同關注的問題。研究表明，五分之一的成年女性一生中至少會患上一次尿道感染。在美國，大約 25% 至 40% 的 20 至 40 歲女性患有尿道結石。美國每年報告約 25 萬例腎盂腎炎病例。在18至19歲的女性中，發生率約為28/10,000，其中7%的病例需要住院治療。遺傳和文化因素可能會影響其盛行率，例如在韓國，腎盂腎炎的發生率約為 59/10,000。男性復發率為 5.7%，女性復發率為 9%，比其他尿道結石更常見。

全球糖尿病盛行率的不斷上升可能導致膀胱炎的增加，因為糖尿病患者罹患急性膀胱炎等尿道感染的風險更高。根據 NCBI 論文，2 型糖尿病會增加尿道結石的風險，且第 2 型糖尿病患者會頻繁出現嚴重的尿道結石。根據國際糖尿病聯盟（IDF）2021年的資料，到2030年，大約有6.43億人將受到糖尿病的影響，到2045年，大約有7.83億人將受到糖尿病的影響。此外，糖尿病女性中無症狀性菌尿的盛行率估計為 26%，而非糖尿病女性中無症狀菌尿的盛行率為 6%。預計這些因素將增加全世界膀胱炎的盛行率。

然而，隨著人們對這些疾病的認知不斷提高，近年來對專科治療的需求也隨之增加。根據美國衛生與公共服務部的數據，2020年美國執業泌尿系統的數量為每10萬人中4.07人。報告進一步指出，由於需求增加，泌尿系統出現短缺，到 2025 年，醫生數量可能會超過近 3,600 名。這可能會阻礙未來年度的市場成長。此外，COVID-19 也對該行業產生了負面影響。尿道結石患者對檢測和緊急醫療護理構成重大障礙。

主要企業正在推出新產品來增強其產品組合。例如，2021 年 9 月，OpGen, Inc. 宣布啟動 Unyvero 泌尿道感染小組的臨床試驗。此面板可以直接從尿液樣本分析多種病原體和抗菌素抗藥性標記物。成功的臨床試驗和此類技術先進、高效產品的推出預計將推動未來年度的市場成長。同樣，2020年7月，泌尿系統健康生物技術公司Uqora (Pharmavite, LLC)推出了尿道結石診斷和管理套件。該套件包括 Clarify，這是一種與 PoC 和居家照護相容的快速尿道結石診斷設備。

尿道感染檢測市場亮點

  • 膀胱炎佔據市場主導地位，預計 2022 年市場佔有率為 41.42%。這是由於膀胱炎的盛行率和復發率較高，產品核可數量不斷增加，以及大量的糖尿病患者易患膀胱炎。
  • 參考實驗室部門在 2022 年佔據 26.66% 的佔有率，因為參考實驗室繼續努力透過提供零售層面的診斷設施來改善患者的治療結果。
  • 以金額為準，北美在整個尿道感染市場中佔據主導地位。這是由於更好的報銷設施以及由於意識的提高而更多地採用新型診斷產品。

目錄

第1章 調查方法和範圍

第2章 執行摘要

第3章 感染檢測市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 普及和成長前景圖
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 尿道感染檢測市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章 感染檢測：按類型估計和趨勢分析

  • 尿道感染檢測市場：重點
  • 尿道感染檢測市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 尿道炎
    • 2018年至2030年尿道炎市場估計與預測
  • 膀胱炎
    • 2018年至2030年膀胱炎市場估計與預測
  • 腎盂腎炎
    • 2018年至2030年腎盂腎炎市場估計與預測

第5章 感染檢測：依最終用途分類的估算與趨勢分析

  • 尿道感染檢測市場：重點
  • 尿道感染檢測市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 全科醫生（GP）
  • 泌尿系統
  • 泌尿婦科醫生
  • 醫院實驗室
  • 參考實驗室
  • 醫院急診部門
  • 緊急護理
  • 其他

第6章 感染檢測市場：按地區估算及趨勢分析

  • 區域展望
  • 尿道感染檢測市場：按地區分類的要點
  • 北美洲
    • 2018-2030 年市場估計與預測
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 市場參與企業分類
    • QIAGEN
    • Accelerate Diagnostics, Inc.
    • Bio-Rad Laboratories, Inc.
    • F. Hoffmann-La Roche Ltd.
    • Danaher
    • Siemens Healthcare GmbH
    • Randox Laboratories Ltd.
    • Thermo Fisher Scientific, Inc.
    • BIOMERIEUX
    • T2 Biosystems, Inc.
Product Code: GVR-4-68039-951-8

Urinary Tract Infection Testing Market Growth & Trends:

The global urinary tract infection testing market is expected to reach USD 812.01 million by 2030, according to a new report by Grand View Research, Inc.. The market is anticipated to grow at a CAGR of 4.4% from 2023 to 2030. The urinary tract infection (UTI) testing market is witnessing growth due to factors such as rising disease burden, increasing geriatric population, rapid technological advancements, and high R&D investments by key players to introduce novel & innovative products, such as self-testing & rapid Point-of-Care (PoC) devices products.

Urinary tract infection is becoming a common global concern. According to research studies, UTI occurs in one in five adult women at some point in their life. In the U.S., about 25%-40% of women aged 20-40 have suffered a UTI. In the U.S., about 250,000 cases of pyelonephritis are reported every year. In women aged 18-19, its incidence is about 28/10,000, out of which 7% of cases require hospital admission. Genetic and cultural factors may influence its prevalence; for instance, in South Korea, the incidence of pyelonephritis is around 59/10,000. Its recurrence is more common than other UTIs, with the recurrence rate being 5.7% in men and 9% in women.

Patients with diabetes are at increased risk of developing urinary tract infections such as acute cystitis, and therefore, the increasing global prevalence of diabetes is likely to contribute to cystitis growth. According to an NCBI article, type 2 diabetes raises UTI risk and patients with type 2 diabetes experience frequent & severe UTIs. According to the International Diabetes Federation (IDF) data from 2021, approximately 643 million individuals will have diabetes by 2030 and 783 million by 2045. Moreover, the estimated prevalence of asymptomatic bacteriuria in diabetic females is 26%, compared to 6% in nondiabetic females. Such factors are expected to boost the prevalence of cystitis globally.

However, due to the rise in awareness about such diseases, the demand for specialist treatment has increased in recent years. According to the U.S. Department of Health and Human Services, in the U.S., the number of practicing urologists in 2020 was 4.07 per 100,000 populations. The report further stated that due to the rise in demand, a shortage of urologists was observed, which is likely to exceed nearly 3,600 physicians by 2025. This can impede market growth in the coming years. Moreover, COVID-19 has had a detrimental impact on the industry. Individuals with UTIs have experienced substantial disruptions in testing and emergency care.

Key players are introducing novel products to strengthen their portfolios. For instance, in September 2021, OpGen, Inc. announced initiating clinical trials of the Unyvero Urinary Tract Infection Panel. The panel can analyze a broad range of pathogens and antimicrobial resistance markers directly from a urine sample. Successful clinical trials and the launch of such technologically advanced & efficient products are anticipated to drive market growth over the coming years. Similarly, in July 2020, Uqora, Inc. (Pharmavite, LLC), a urinary health biotechnology company, launched a UTI diagnostic and management kit. The kit includes a rapid UTI diagnostic device, Clarify, compatible with a PoC and homecare setting.

Urinary Tract Infection Testing Market Highlights

  • Cystitis dominated the market in 2022, with an estimated market share of 41.42%. This can be attributed to the high incidence & recurrence rate of cystitis, increased number of product approvals, and the high number of diabetes patients who are more prone to cystitis
  • The reference laboratories segment held a share of 26.66% in 2022 attributed to the ongoing efforts of reference laboratories to enhance patient outcomes by offering diagnostic facilities at retail level.
  • North America dominated the overall urinary tract infection market in terms of value. This can be attributed to better reimbursement facilities and a rise in the adoption of novel diagnostic products due to increased awareness

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Type
    • 1.1.2. End Use
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. End Use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Urinary Tract Infection Testing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Urinary Tract Infection Testing Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Urinary Tract Infection Testing: Type Estimates & Trend Analysis

  • 4.1. Urinary Tract Infection Testing Market: Key Takeaways
  • 4.2. Urinary Tract Infection Testing Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Urethritis
    • 4.3.1. Urethritis market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Cystitis
    • 4.4.1. Cystitis market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Pyelonephritis
    • 4.5.1. Pyelonephritis market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Urinary Tract Infection Testing: End Use Estimates & Trend Analysis

  • 5.1. Urinary Tract Infection Testing Market: Key Takeaways
  • 5.2. Urinary Tract Infection Testing Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. General Practitioners (GPs)
    • 5.3.1. General practitioners (GPs) market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Urologists
    • 5.4.1. Urologists market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Urogynecologists
    • 5.5.1. Urogynecologists market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Hospital Laboratories
    • 5.6.1. Hospital laboratories market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.7. Reference Laboratories
    • 5.7.1. Reference laboratories market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.8. Hospital Emergency Departments
    • 5.8.1. Hospital emergency departments market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.9. Urgent Care
    • 5.9.1. Urgent care market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.10. Others
    • 5.10.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Urinary Tract Infection Testing Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Urinary Tract Infection Testing Market by Region: Key Takeaway
  • 6.3. North America
    • 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.3. France
      • 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.6. Sweden
      • 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.7. Norway
      • 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.2. China
      • 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.3. India
      • 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.5. Thailand
      • 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.6. South Korea
      • 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. Mexico
      • 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7. MEA
    • 6.7.1. Saudi Arabia
      • 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Market Participant Categorization
    • 7.2.1. QIAGEN
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Accelerate Diagnostics, Inc.
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. Bio-Rad Laboratories, Inc.
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. F. Hoffmann-La Roche Ltd.
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. Danaher
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. Siemens Healthcare GmbH
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. Randox Laboratories Ltd.
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Thermo Fisher Scientific, Inc.
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. BIOMERIEUX
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives
    • 7.2.10. T2 Biosystems, Inc.
      • 7.2.10.1. Company overview
      • 7.2.10.2. Financial performance
      • 7.2.10.3. Product benchmarking
      • 7.2.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 3 North America urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 4 North America urinary tract infection testing market, by region, 2018 - 2030 (USD Million)
  • Table 5 U.S. urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 6 U.S. urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 7 Canada urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 8 Canada urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Europe urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 10 Europe urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 11 Europe urinary tract infection testing market, by region, 2018 - 2030 (USD Million)
  • Table 12 Germany urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 13 Germany urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 14 UK urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 15 UK urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 16 France urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 17 France urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 18 Italy urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 19 Italy urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 20 Spain urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 21 Spain urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 22 Sweden urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 23 Sweden urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 24 Norway urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 25 Norway urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 26 Denmark urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 27 Denmark urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific urinary tract infection testing market, by region, 2018 - 2030 (USD Million)
  • Table 31 China urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 32 China urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 33 Japan urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 34 Japan urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 35 India urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 36 India urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 37 Thailand urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 38 Thailand urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 39 South Korea urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 40 South Korea urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Latin America urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 42 Latin America urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 43 Latin America urinary tract infection testing market, by region, 2018 - 2030 (USD Million)
  • Table 44 Brazil urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 45 Brazil urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 46 Mexico urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 47 Mexico urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 48 Argentina urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 49 Argentina urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 50 Middle East and Africa urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 51 Middle East and Africa urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 52 Middle East and Africa urinary tract infection testing market, by region, 2018 - 2030 (USD Million)
  • Table 53 South Africa urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 54 South Africa urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 55 Saudi Arabia urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 56 Saudi Arabia urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 57 UAE urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 58 UAE urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 59 Kuwait urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 60 Kuwait urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Urinary tract infection testing: Market outlook
  • Fig. 9 Urinary tract infection testing: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Urinary tract infection testing market driver impact
  • Fig. 15 Urinary tract infection testing market restraint impact
  • Fig. 16 Urinary tract infection testing market strategic initiatives analysis
  • Fig. 17 Urinary tract infection testing market: Type movement analysis
  • Fig. 18 Urinary tract infection testing market: Type outlook and key takeaways
  • Fig. 19 Urethritis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Cystitis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Pyelonephritis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Urinary tract infection testing market: End use movement analysis
  • Fig. 23 Urinary tract infection testing market: End use outlook and key takeaways
  • Fig. 24 General practitioners (GPs) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Urologists market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Urogynecologists market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Hospital laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Reference laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Hospital emergency departments market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Urgent care market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Global urinary tract infection testing market: Regional movement analysis
  • Fig. 33 Global urinary tract infection testing market: Regional outlook and key takeaways
  • Fig. 34 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)